Companies: 10,795·Total market cap: $144.5T
NKGen Biotech, Inc. Common Stock

NKGen Biotech, Inc. Common Stock

NKGNOTCHealthcare● Active
$0.06
+$0.00(+0.00%)
Market Cap$7836133
P/E Ratio
52W High$0.765
52W Low$0.001
Overview

NKGen Biotech, Inc. Common Stock (NKGN) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · NKGN · as of Oct 8, 2025

Latest filing snapshot

26
-37-58.73%vs prior year

NKGen Biotech, Inc. Common Stock (NKGN) employee data is sourced from the annual SEC 10-K filing. As of 2024, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2024-12-31·Full-time · Global
Total Employees
26
Change (1Y)
-37
Growth % (1Y)
-58.73%
Revenue / Employee
Net Income / Employee
$-1.70M
Market Cap
$8M

NKGN Employee Count

2021 – 2024 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2025-10-0826-37-58.73%
2024-04-1663+59+1475.00%
2023-03-314-2-33.33%
2022-03-316

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Moolec Science S.A.
MLEC
Moolec Science S.A.
52
#2
NKGen Biotech, Inc. Common Stock
NKGN
NKGen Biotech, Inc. Common StockYOU
26
#3
BriaCell Therapeutics Corp. Warrant
BCTXZ
BriaCell Therapeutics Corp. Warrant
16
#4
NewcelX Ltd.
NCEL
NewcelX Ltd.
11
#5
Dermata Therapeutics, Inc.
DRMA
Dermata Therapeutics, Inc.
8
#6
Avenue Therapeutics, Inc.
ATXI
Avenue Therapeutics, Inc.
2
#7
PMGC Holdings Inc.
ELAB
PMGC Holdings Inc.
2
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · NKGN peer comparison

About NKGN employees

NKGN Employees · Headcount

NKGen Biotech, Inc. Common Stock (NKGN) employee data is sourced from the annual SEC 10-K filing. As of 2024, NKGen Biotech, Inc. Common Stock had 26 full-time employees globally. Full-time employees only. Global consolidated headcount.

NKGen Biotech, Inc. Common Stock's workforce decreased by 37 (58.73%) in 2024 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Frequently Asked Questions

NKGN Employees · 5 questions

As of the latest SEC 10-K filing (2024), NKGen Biotech, Inc. Common Stock had 26 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

NKGen Biotech, Inc. Common Stock employee counthow many employees does NKGen Biotech, Inc. Common Stock haveNKGN total employees 2024

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2025-10-08